FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and medicine, and concerns a pharmaceutical combined composition for treating and preventing hypertension in patients with diabetes, ventricular hypertrophy in patients with diabetes for the purpose of delay of progression of diabetic renal diseases or for the purpose of reduction of proteinuria in patients with diabetes, containing the AT1-antagonist valsartan or its pharmaceutically acceptable salt and calcium canal blocker which is presented by amlodipine benzylate, and a pharmaceutically acceptable carrier.
EFFECT: preparing the pharmaceutical combined composition for treating or preventing hypertension.
3 cl, 3 tbl
Authors
Dates
2012-05-20—Published
1999-07-09—Filed